Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voclosporin vs Restasis in Dry Eye Disease
NCT03597139Phase 2Completed
- Sponsor
- Aurinia
- Start
- Aug 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Voclosporin ophthalmic solution in dry eye disease (DED) (2 arms), sponsored by Aurinia. Primary endpoint: Change From Baseline in Drop Discomfort Post Dose Instillation at Day 1. Started Aug 2018; status: completed.
02
Drugs
Voclosporin ophthalmic solution
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03597139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03597139.